Literature DB >> 12719593

The vaccinia virus I3L gene product is localized to a complex endoplasmic reticulum-associated structure that contains the viral parental DNA.

Sonja Welsch1, Laura Doglio, Sibylle Schleich, Jacomine Krijnse Locker.   

Abstract

The vaccinia virus (VV) I3L gene product is a single-stranded DNA-binding protein made early in infection that localizes to the cytoplasmic sites of viral DNA replication (S. C. Rochester and P. Traktman, J. Virol. 72:2917-2926, 1998). Surprisingly, when replication was blocked, the protein localized to distinct cytoplasmic spots (A. Domi and G. Beaud, J. Gen. Virol. 81:1231-1235, 2000). Here these I3L-positive spots were characterized in more detail. By using an anti-I3L peptide antibody we confirmed that the protein localized to the cytoplasmic sites of viral DNA replication by both immunofluorescence and electron microscopy (EM). Before replication had started or when replication was inhibited with hydroxyurea or cytosine arabinoside, I3L localized to distinct cytoplasmic punctate structures of homogeneous size. We show that these structures are not incoming cores or cytoplasmic sites of VV early mRNA accumulation. Instead, morphological and quantitative data indicate that they are specialized sites where the parental DNA accumulates after its release from incoming viral cores. By EM, these sites appeared as complex, electron-dense structures that were intimately associated with the cellular endoplasmic reticulum (ER). By double labeling of cryosections we show that they contain DNA and a viral early protein, the gene product of E8R. Since E8R is a membrane protein that is able to bind to DNA, the localization of this protein to the I3L puncta suggests that they are composed of membranes. The results are discussed in relation to our previous data showing that the process of viral DNA replication also occurs in close association with the ER.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719593      PMCID: PMC154049          DOI: 10.1128/jvi.77.10.6014-6028.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Relationship between vaccinia virus intracellular cores, early mRNAs, and DNA replication sites.

Authors:  Massimo Mallardo; Edward Leithe; Sibylle Schleich; Norbert Roos; Laura Doglio; Jacomine Krijnse Locker
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

2.  THE INTRACELLULAR UNCOATING OF POXVIRUS DNA. I. THE FATE OF RADIOACTIVELY-LABELED RABBITPOX VIRUS.

Authors:  W K JOKLIK
Journal:  J Mol Biol       Date:  1964-02       Impact factor: 5.469

3.  Vaccinia virus membrane proteins p8 and p16 are cotranslationally inserted into the rough endoplasmic reticulum and retained in the intermediate compartment.

Authors:  T Salmons; A Kuhn; F Wylie; S Schleich; J R Rodriguez; D Rodriguez; M Esteban; G Griffiths; J K Locker
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 4.  Regulation of vaccinia virus transcription.

Authors:  B Moss
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

5.  Microtubule-dependent organization of vaccinia virus core-derived early mRNAs into distinct cytoplasmic structures.

Authors:  M Mallardo; S Schleich; J Krijnse Locker
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

6.  Vaccinia virus DNA replication occurs in endoplasmic reticulum-enclosed cytoplasmic mini-nuclei.

Authors:  N Tolonen; L Doglio; S Schleich; J Krijnse Locker
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

7.  The Vaccinia virus E8R gene product: a viral membrane protein that is made early in infection and packaged into the virions' core.

Authors:  Laura Doglio; Ario De Marco; Sibylle Schleich; Norbert Roos; Jacomine Krijnse Locker
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  The multistep proteolytic maturation pathway utilized by vaccinia virus P4a protein: a degenerate conserved cleavage motif within core proteins.

Authors:  J K Vanslyke; S S Whitehead; E M Wilson; D E Hruby
Journal:  Virology       Date:  1991-08       Impact factor: 3.616

9.  Another triple-spanning envelope protein among intracellularly budding RNA viruses: the torovirus E protein.

Authors:  J A Den Boon; E J Snijder; J K Locker; M C Horzinek; P J Rottier
Journal:  Virology       Date:  1991-06       Impact factor: 3.616

10.  Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks.

Authors:  B Sodeik; R W Doms; M Ericsson; G Hiller; C E Machamer; W van 't Hof; G van Meer; B Moss; G Griffiths
Journal:  J Cell Biol       Date:  1993-05       Impact factor: 10.539

View more
  19 in total

1.  The poxviral RING protein p28 is a ubiquitin ligase that targets ubiquitin to viral replication factories.

Authors:  Bianca T Hovey Nerenberg; John Taylor; Eric Bartee; Kristine Gouveia; Michele Barry; Klaus Früh
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  A trans-Golgi network resident protein, golgin-97, accumulates in viral factories and incorporates into virions during poxvirus infection.

Authors:  Dina Alzhanova; Dennis E Hruby
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

Review 3.  Poxvirus DNA replication.

Authors:  Bernard Moss
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

4.  Structural insight into BH3 domain binding of vaccinia virus antiapoptotic F1L.

Authors:  Stephanie Campbell; John Thibault; Ninad Mehta; Peter M Colman; Michele Barry; Marc Kvansakul
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

5.  Diversity in the acute CD8 T cell response to vaccinia virus in humans.

Authors:  Lichen Jing; Tiana M Chong; Christopher L McClurkan; Jay Huang; Brian T Story; David M Koelle
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

6.  Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.

Authors:  Christine Pugh; Sarah Keasey; Lawrence Korman; Phillip R Pittman; Robert G Ulrich
Journal:  Clin Vaccine Immunol       Date:  2014-04-23

7.  Molecular genetic and biochemical characterization of the vaccinia virus I3 protein, the replicative single-stranded DNA binding protein.

Authors:  Matthew D Greseth; Kathleen A Boyle; Matthew S Bluma; Bethany Unger; Matthew S Wiebe; Jamaria A Soares-Martins; Nadi T Wickramasekera; James Wahlberg; Paula Traktman
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

Review 8.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

9.  Orthopoxviruses require a functional ubiquitin-proteasome system for productive replication.

Authors:  Alastair Teale; Stephanie Campbell; Nick Van Buuren; Wendy C Magee; Kelly Watmough; Brianne Couturier; Robyn Shipclark; Michele Barry
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

10.  Vaccinia virus DNA ligase recruits cellular topoisomerase II to sites of viral replication and assembly.

Authors:  Y-C James Lin; Jianhong Li; Chad R Irwin; Heather Jenkins; Luke DeLange; David H Evans
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.